Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2020-08, Vol.76 (2), p.e15-e17
Main Authors: Zhou, Feng, Liu, Ye-Mao, Xie, Jing, Li, Haomiao, Lei, Fang, Yang, Huilin, Qin, Juan-Juan, Cai, Jingjing, Zhang, Xiao-Jing, Wu, Bin, Xia, Meng, Xiang, Da, Yang, Chengzhang, Ma, Xinliang, Xu, Qingbo, Lu, Zhigang, Lu, Haofeng, Xia, Xigang, Wang, Daihong, Liao, Xiaofeng, Peng, Gang, Yang, Jun, Huang, Xiaodong, Zhang, Bing-Hong, Yuan, Yufeng, Wei, Xiang, Liu, Peter P., Wang, Yibin, Zhang, Peng, She, Zhi-Gang, Xia, Jiahong, Li, Hongliang
Format: Article
Language:English
Subjects:
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Angiotensins
Betacoronavirus
Coronavirus Infections
COVID-19
Humans
Pandemics
Pneumonia, Viral
Renin-Angiotensin System
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0194-911X
1524-4563
DOI:10.1161/HYPERTENSIONAHA.120.15622